Toll-like receptor-mediated production of IL-1Ra is negatively regulated by GSK3 via the MAPK ERK1/2. - Wikidata - wikimedia - TriplyDB

Toll-like receptor-mediated production of IL-1Ra is negatively regulated by GSK3 via the MAPK ERK1/2.

Toll-like receptor-mediated production of IL-1Ra is negatively regulated by GSK3 via the MAPK ERK1/2.

http://www.wikidata.org/entity/Q33771582

about

Glycogen synthase kinase 3: a point of convergence for the host inflammatory response GSK3β and the control of infectious bacterial diseases Phagocytosed Clofazimine Biocrystals Can Modulate Innate Immune Signaling by Inhibiting TNFα and Boosting IL-1RA Secretion Protective effects of pretreatment with oleanolic acid in rats in the acute phase of hepatic ischemia-reperfusion injury: role of the PI3K/Akt pathway.Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3).Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death Glatiramer acetate triggers PI3Kδ/Akt and MEK/ERK pathways to induce IL-1 receptor antagonist in human monocytes.A20 is critical for the induction of Pam3CSK4-tolerance in monocytic THP-1 cells Convergence of the mammalian target of rapamycin complex 1- and glycogen synthase kinase 3-β-signaling pathways regulates the innate inflammatory response.Mammalian target of rapamycin (mTOR) regulates TLR3 induced cytokines in human oral keratinocytes.Glycogen synthase kinase 3β ubiquitination by TRAF6 regulates TLR3-mediated pro-inflammatory cytokine production Cytokine-induced monocyte MMP-1 is negatively regulated by GSK-3 through a p38 MAPK-mediated decrease in ERK1/2 MAPK activation.Glycogen synthase kinase-3 controls IL-10 expression in CD4(+) effector T-cell subsets through epigenetic modification of the IL-10 promoter.MT1-MMP regulates the PI3Kδ·Mi-2/NuRD-dependent control of macrophage immune function.Neutrophils in periodontal inflammation Inhibition of GSK3 abolishes bacterial-induced periodontal bone loss in mice.The role of glycogen synthase kinase 3 in regulating IFN-β-mediated IL-10 production.The role of JAK-3 in regulating TLR-mediated inflammatory cytokine production in innate immune cells.Glycogen synthase kinase 3β in Toll-like receptor signaling.Sustained elevation of Snail promotes glial-mesenchymal transition after irradiation in malignant glioma.Phosphodiesterase 4B negatively regulates endotoxin-activated interleukin-1 receptor antagonist responses in macrophages.New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.Role of glycogen synthase kinase-3 beta in the inflammatory response caused by bacterial pathogens The role of glycogen synthase kinase 3-β in immunity and cell cycle: implications in esophageal cancer.Interleukin-1 receptor antagonist mediates toll-like receptor 3-induced inhibition of trophoblast adhesion to endometrial cells in vitro.Neuroprotective effects of pretreatment with propofol in LPS-induced BV-2 microglia cells: role of TLR4 and GSK-3β.GSK3beta Inhibitor Peptide Protects Mice from LPS-induced Endotoxin Shock.Investigation of POPX2 phosphatase functions by comparative phosphoproteomic analysis.TNFα disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice.Phosphatidylinositol-3-kinase activity during in vitro dendritic cell generation determines suppressive or stimulatory capacity.Fractional factorial design to investigate stromal cell regulation of macrophage plasticity.Lithium chloride antileukemic activity in acute promyelocytic leukemia is GSK-3 and MEK/ERK dependent.A novel MEK2/PI3Kδ pathway controls the expression of IL-1 receptor antagonist in IFN-β-activated human monocytes.GSK3β inhibition attenuates LPS-induced IL-6 expression in porcine adipocytes

P2860

Q24597129-DDB3670F-B31A-4860-887A-235A327464AB Q27013766-78D1D22F-2439-4247-8B3D-E003EDA5DDBB Q27301088-D0B5B3EA-216A-46F7-B24D-B040C3150FC9 Q33562749-C2510380-F342-4B04-8B71-7B5A614D5D47 Q33636704-0DFF26A2-A50A-41A7-8A9C-F278269787CA Q33710200-7C316BC8-7A2B-447F-AC9B-661A0A0A7EA1 Q34200072-BC11C006-5143-4A9A-A7C4-8393BA1CAA5F Q35086715-A3E9E5DF-5182-47A0-AAAC-60C7DA19EA8B Q35108092-77E0CAB8-D092-4EAB-BBC8-B94A9E001A21 Q35213190-681A629C-D564-4580-B777-E856ECCA710C Q35407394-55B7A6DF-CF13-4A50-92B0-BE96C978A7E9 Q35430731-89FF7A47-95CD-4AB8-91FA-67E84AEC1FD2 Q35509305-16C2C9CF-02B8-4610-9C7A-716060D37A98 Q35788951-6835F146-8B11-4114-97BB-6BAFDF8C4D13 Q35909279-E574A696-B012-4B9E-82E5-4F31B93A3C33 Q36434353-AF08E7B7-6414-443B-BB7A-524963981A72 Q36712311-3F4D7977-29EC-4D5C-8AB6-060DA651B408 Q37039005-C4079D32-6BEB-4EE4-8F85-6DBCD741D70E Q37351177-25D3A75B-01D0-47EF-83CD-8331CE09A26D Q37699420-C8431918-CA40-438C-9293-CAE82392AC80 Q37739683-87FEFBDE-CE04-4B35-89A2-2DA597A74E93 Q37978196-ED0A12A5-8950-4F63-91D5-817FC24473DB Q38018171-9821A76F-2FB1-439B-8CDB-521D139A9DCB Q38166249-7A2EC4D1-99A2-4DA8-8FD0-AC7DAA549732 Q38758328-1CBD5F2C-683E-4A10-BC52-A79F084D7BED Q39347916-3A217AD9-F392-428E-8DA5-0B5D61B0E2E2 Q42063971-DE48864D-4895-44D8-AE23-EAEB64760673 Q42809734-99B30D30-E141-4546-A764-F3EC6D2903D4 Q49923118-6E584EE6-A71F-4A88-9C32-753C6462E1B1 Q53255338-9E6A4922-95B6-4548-A0E7-7BA604BB804A Q53535494-EBC9A8DA-00B3-4E71-B333-EB4BD4096BEA Q54263446-AECFE280-6AFD-4433-AA63-F2CAEF7C0AE3 Q54650268-95B6BF61-A4FA-4BCF-A504-7CDC7C29C122 Q58107361-C86AF28F-FC53-4C6F-B437-974FB32D0209

P2860

Toll-like receptor-mediated production of IL-1Ra is negatively regulated by GSK3 via the MAPK ERK1/2.

http://www.wikidata.org/entity/Q33771582

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Toll-like receptor-mediated pr ...... d by GSK3 via the MAPK ERK1/2.

@ast

Toll-like receptor-mediated pr ...... d by GSK3 via the MAPK ERK1/2.

@en

type

label

Toll-like receptor-mediated pr ...... d by GSK3 via the MAPK ERK1/2.

@ast

Toll-like receptor-mediated pr ...... d by GSK3 via the MAPK ERK1/2.

@en

prefLabel

Toll-like receptor-mediated pr ...... d by GSK3 via the MAPK ERK1/2.

@ast

Toll-like receptor-mediated pr ...... d by GSK3 via the MAPK ERK1/2.

@en

P1433

Q33771582-A4D402C8-803C-44F9-9BB4-A6A1F5A6E783

P1476

Q33771582-8051DA6C-9726-4389-8926-68B3994098AC

P2093

Q33771582-840C546A-EEEB-4A8D-9D18-C6187B8FA649

Q33771582-AF168CA9-6B1B-41BA-A428-B45CC1BE19FF

Q33771582-C2473695-8FC8-407F-AD29-F650D502B3E6

Q33771582-CE386949-7625-4140-8192-C16BA3685E9D

Q33771582-E7789923-805E-4846-B708-FCBDF4CD781C

P2860

Q33771582-015DFF40-CA5E-42E5-BCB8-2985AC70C283

Q33771582-0578D03D-4332-4E23-985C-E11F03D57A9C

Q33771582-0701685D-695A-4C21-8802-4A4C17F18109

Q33771582-1201BB9C-CFB2-4E79-8C0C-AE6F2FD48B4B

Q33771582-1BD807AD-E5AA-434F-A51B-2488C53EBAAC

Q33771582-21A88417-1FE1-4D56-A41E-25ACF9934C0A

Q33771582-2A3E3AB4-9007-46A9-AC06-4EE133F9B273

Q33771582-2C607E67-8319-4EEB-9AA5-39D925321894

Q33771582-32B790BF-9F82-47BA-8ABC-F6B648D9DFBC

Q33771582-3498E292-61EF-4E21-9E41-F27538258F4B

P304

Q33771582-056A1B1F-EE7C-47F7-9FD4-7CBD6CB63E78

P31

Q33771582-1D95A716-0E4F-4C26-ACBA-E4C26144B4AF

P356

Q33771582-F991DABF-7CA1-4D05-B383-C8DBA8025041

P407

Q33771582-E672F7DD-F076-4135-96FC-16F84E0BF896

P433

Q33771582-C79DA960-B62E-4A57-B085-A4B4C456A8F6

P478

Q33771582-7046757A-6098-4D3F-A97A-D4E562431E52

P577

Q33771582-AC7E7056-9148-4925-B340-F1950667551F

P5875

Q33771582-203FBECA-E9A8-4EFC-8585-9F70E2237C0A

P698

Q33771582-9B699651-BB31-46BB-BE1A-1B5D4AF5C410

P921

Q33771582-8db3c0da-9a16-4d25-a8ec-e27ab5fb2b5c

P932

Q33771582-1F631C80-B0CA-45E1-B393-76D13AB8F300

P356

JIMMUNOL.182.1.547

P1433

Journal of Immunology

P1476

Toll-like receptor-mediated pr ...... d by GSK3 via the MAPK ERK1/2.

@en

P2093

Carlos A Garcia

http://www.w3.org/2001/XMLSchema#string

Denis F Kinane

http://www.w3.org/2001/XMLSchema#string

Huizhi Wang

http://www.w3.org/2001/XMLSchema#string

Kunal Rehani

http://www.w3.org/2001/XMLSchema#string

Michael Martin

http://www.w3.org/2001/XMLSchema#string

P2860

Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells

Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

Phosphorylation and regulation of Raf by Akt (protein kinase B)

The balance between IL-1 and IL-1Ra in disease

Presenilin couples the paired phosphorylation of beta-catenin independent of axin: implications for beta-catenin activation in tumorigenesis

IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?

Selective regulation of cytokine induction by adenoviral gene transfer of IkappaBalpha into human macrophages: lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-kappaB independe

The discovery of potent cRaf1 kinase inhibitors

P304

547-553

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.182.1.547

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

182

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23699269

http://www.w3.org/2001/XMLSchema#string

P698

19109187

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

2850057

http://www.w3.org/2001/XMLSchema#string